Advanced Proteome Therapeutics Reports Positive Results and Advances Collaboration with Heidelberg Pharma
pharmaceutical investing Advanced Proteome Therapeutics Announces Progress on Antibody-Radioisotope Conjugate Initiative
EraNova Announces Positive Preliminary Economic Assessment for the Adanac Molybdenum Project: After-Tax NPV of $714.4 Million and 23.5% IRR
